Cerebral ischemia is a common cerebrovascular disease, and its treatment goals are to restore brain blood flow as soon as possible, reduce brain tissue damage, and prevent recurrence. At Protheragen, our anti-cerebral ischemia APIs effectively protect brain tissue from ischemia-reperfusion injury through multiple mechanisms such as improving brain microcirculation, inhibiting platelet aggregation, reducing oxidative stress and neuroinflammation.
Protheragen offers a full range of anti-cerebral ischemia APIs to support our customers' research worldwide.
Cat | Product Name | Cas | Details | Chemical Structure |
---|---|---|---|---|
API6066495 | 3-butylphthalide | 6066-49-5 | View Details |
![]() |
Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed